ANEB

Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)

About Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.

Details

Daily high

$1.17

Daily low

$1.09

Price at open

$1.10

52 Week High

$3.08

52 Week Low

$0.80

Market cap

46.0M

Dividend yield

0.00%

Volume

24,907

Avg. volume

12,213

P/E ratio

-4.19

Anebulo Pharmaceuticals, Inc. - Common Stock News